coronary heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Aged >= 18 years and 90 ml/min/1.73m² (non-CKD); 4.The patient himself/herself or the designated agent consents to participate in this study; 5.Commits to complying with the research procedures and cooperating with the implementation of the entire research process;
Exclusion criteria
Exclusion criteria: 1.Allergy to iodine contrast agents; 2.Complicated with rheumatic immune diseases; 3.Complicated with malignant tumors; 4.Chronic infection during coronary artery stent implantation; 5.Familial hypercholesterolemia; 6.Patients with an expected lifespan of = 1 year; 7.Being pregnant or lactating; 8.Patients deemed by researchers to have poor compliance and unable to complete follow-up;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In-Stent Restenosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of MACE; | — |
Countries
China
Contacts
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine